Glomerular Diseases: IgAN, IgA Vasculitis, and More
October 22, 2026 | 10:00 AM - 12:00 PM
Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
Posters
Glomerular Diseases: IgAN, IgA Vasculitis, and More
October 22, 2026 | 10:00 AM - 12:00 PM
Location: Exhibit Hall A, Convention Center
Session Description
Poster Session
Posters
An Unusual Case of Hyperpigmentation in a Patient with Crescentic IgAN Treated with Cyclophosphamide
Two Hits, One Kidney: Unveiling Alport Syndrome in Progressive IgAN
Active IgA-Dominant Infection-Related Glomerulonephritis Despite Sustained Bacterial Eradication Subsequently Mitigated with Corticosteroids
Breaking Resistance: Successful Treatment of Refractory Nephrotic Syndrome with a Nonstandard Treatment (Upadacitinib)
IgA Vasculitis Superimposed on IgAN After COVID-19 in Adulthood: A Christmas Special
Hydralazine-Induced IgA Vasculitis in a Dialysis-Dependent Patient with Primary IgAN: A Case with Positive Rechallenge
Occam's Razor or Hickam's Dictum: Systemic Autoimmune Disarray
Adalimumab-Associated IgAN in a Patient with Recurrent Scleritis
Distant Triggers of IgAN
Layered Precision Therapy for Advanced IgAN Beyond Trial Eligibility: Thirteen-Month Real-World Experience with Targeted-Release Formulation (TRF)-Budesonide and Atrasentan
Minimal Change Disease-IgAN Overlap Presenting as Severe Nephrotic Syndrome
Real-World Use of Iptacopan in Treatment-Resistant Crescentic IgAN
Lysozyme-Induced Nephropathy (LyN): A Rare Cause of CKD in a Patient with Chronic Myelomonocytic Leukemia 1 (CMML-1)
Renal Recovery in Dialysis-Dependent Crescentic IgA Vasculitis: Abbreviated Cyclophosphamide and Rituximab-Based Induction in an Older Patient
Combination Therapy in IgAN: A Real-World Case Demonstrating Rapid Reduction in Proteinuria
Use of Endothelin Receptor Blockade in Patients with IgAN and Advanced CKD: A Case Series
Not All Proteinuria in Lupus Is Lupus Nephritis: IgAN in a Patient with Systemic Lupus Erythematosus and Antiphospholipid Syndrome
Real-World Experience of Sequential Targeted-Release Formulation (TRF)-Budesonide and Sparsentan Therapy in Patients with IgAN: A Case Series
Proteinuria Without Progression: Unmasking Monoclonal Glomerular Disease in a Patient with Known IgAN
Lucio Phenomenon with IGAN Presenting as AKI in Untreated Lepromatous Leprosy: A Case Report
A Challenging Case of IgAN and Vasculitis Complicating Nivolumab Therapy for Hodgkin Lymphoma
Biologic Therapy and Renal Autoimmunity: A Case of Infliximab-Associated Crescentic IgAN in Crohn Disease
A Rare Case of IgAN in a 20-Year-Old Patient with Negative DNAJB9 and Congo Red Fibrillary Deposits
Case of Isolated Proteinuria That Resolves with Rest
Dual-Disease Management: Combining Biologic and Mucosal-Targeted Therapy in Ankylosing Spondylitis (AS) and IgAN
Fulminant Crescentic IgAN with Renal-Limited Thrombotic Microangiopathy Progressing to Kidney Failure Despite Complement Inhibition
Refractory Nephrotic Syndrome Treated with Off-Label Obinutuzumab
An Unusual Case of Crescentic IgAN That Exemplifies the Complexity of Diagnosis and Management
Infection-Related Glomerular Injury: Malaria Unmasking IgAN
When Biopsy Raises More Questions Than Answers: Immune-Mediated Glomerulonephritis (GN) in a Pregnant Appalachian Woman
Proteinuria in Diagnostic Limbo: Unraveling an Atypical Cause of Proteinuria
Biopsy-Proven IgAN in a Patient with Longstanding Diabetes and Progressive CKD
IgAN: An Inside Job
Concomitant Biopsy-Proven ANCA-Associated Vasculitis (AAV) and Skin IgA Vasculitis
A Case on Emerging Therapies in Refractory IgAN
The Great Masquerade: Beyond Textbook Seronegative Immune Complex Glomerulopathy
How Late Is Too Late? Treating Advanced IgAN
Who's in the Driver's Seat? IgAN vs. FSGS as Competing Drivers of Progressive CKD in the Setting of a Variant of Uncertain Significance
Crohn Disease Complicated by IgA Vasculitis-Associated Nephritis: Renal Outcomes After Ustekinumab-Maintained Intestinal Remission
Under the Shadow of Stones: Adalimumab-Induced IgA Vasculitis with Renal Involvement
A Toothache with a Twist: Dental Abscess Unmasking IgAN
IgAN-Associated Systemic Lupus Erythematosus
Combination Therapy in IgAN: A Patient Treated with Atrasentan and Targeted-Release Budesonide
Living with IgAN: A Patient Diary Study
Deep Shotgun Metagenomics Reveals Plasmid-Mediated Oral Microbial Mechanisms Underlying Pathogenic IgA Production in IgAN
Early Repeated Administration of a Novel IgG-Degrading Enzyme, Ricefidase, for Anti-GBM Disease: A Phase 2, Open-Label, Single-Arm, Multicenter Study
An Unusual Case of Hyperpigmentation in a Patient with Crescentic IgAN Treated with Cyclophosphamide
October 22, 2026 | 10:00 AM - 12:00 PM
Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
Two Hits, One Kidney: Unveiling Alport Syndrome in Progressive IgAN
October 22, 2026 | 10:00 AM - 12:00 PM
Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
Active IgA-Dominant Infection-Related Glomerulonephritis Despite Sustained Bacterial Eradication Subsequently Mitigated with Corticosteroids
October 22, 2026 | 10:00 AM - 12:00 PM
Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
Breaking Resistance: Successful Treatment of Refractory Nephrotic Syndrome with a Nonstandard Treatment (Upadacitinib)
October 22, 2026 | 10:00 AM - 12:00 PM
Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
IgA Vasculitis Superimposed on IgAN After COVID-19 in Adulthood: A Christmas Special
October 22, 2026 | 10:00 AM - 12:00 PM
Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
Hydralazine-Induced IgA Vasculitis in a Dialysis-Dependent Patient with Primary IgAN: A Case with Positive Rechallenge
October 22, 2026 | 10:00 AM - 12:00 PM
Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
Occam's Razor or Hickam's Dictum: Systemic Autoimmune Disarray
October 22, 2026 | 10:00 AM - 12:00 PM
Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
Adalimumab-Associated IgAN in a Patient with Recurrent Scleritis
October 22, 2026 | 10:00 AM - 12:00 PM
Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
Distant Triggers of IgAN
October 22, 2026 | 10:00 AM - 12:00 PM
Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
Layered Precision Therapy for Advanced IgAN Beyond Trial Eligibility: Thirteen-Month Real-World Experience with Targeted-Release Formulation (TRF)-Budesonide and Atrasentan
October 22, 2026 | 10:00 AM - 12:00 PM
Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
Minimal Change Disease-IgAN Overlap Presenting as Severe Nephrotic Syndrome
October 22, 2026 | 10:00 AM - 12:00 PM
Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
Real-World Use of Iptacopan in Treatment-Resistant Crescentic IgAN
October 22, 2026 | 10:00 AM - 12:00 PM
Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
Lysozyme-Induced Nephropathy (LyN): A Rare Cause of CKD in a Patient with Chronic Myelomonocytic Leukemia 1 (CMML-1)
October 22, 2026 | 10:00 AM - 12:00 PM
Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
Renal Recovery in Dialysis-Dependent Crescentic IgA Vasculitis: Abbreviated Cyclophosphamide and Rituximab-Based Induction in an Older Patient
October 22, 2026 | 10:00 AM - 12:00 PM
Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
Combination Therapy in IgAN: A Real-World Case Demonstrating Rapid Reduction in Proteinuria
October 22, 2026 | 10:00 AM - 12:00 PM
Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
Use of Endothelin Receptor Blockade in Patients with IgAN and Advanced CKD: A Case Series
October 22, 2026 | 10:00 AM - 12:00 PM
Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
Not All Proteinuria in Lupus Is Lupus Nephritis: IgAN in a Patient with Systemic Lupus Erythematosus and Antiphospholipid Syndrome
October 22, 2026 | 10:00 AM - 12:00 PM
Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
Real-World Experience of Sequential Targeted-Release Formulation (TRF)-Budesonide and Sparsentan Therapy in Patients with IgAN: A Case Series
October 22, 2026 | 10:00 AM - 12:00 PM
Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
Proteinuria Without Progression: Unmasking Monoclonal Glomerular Disease in a Patient with Known IgAN
October 22, 2026 | 10:00 AM - 12:00 PM
Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
Lucio Phenomenon with IGAN Presenting as AKI in Untreated Lepromatous Leprosy: A Case Report
October 22, 2026 | 10:00 AM - 12:00 PM
Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
A Challenging Case of IgAN and Vasculitis Complicating Nivolumab Therapy for Hodgkin Lymphoma
October 22, 2026 | 10:00 AM - 12:00 PM
Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
Biologic Therapy and Renal Autoimmunity: A Case of Infliximab-Associated Crescentic IgAN in Crohn Disease
October 22, 2026 | 10:00 AM - 12:00 PM
Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
A Rare Case of IgAN in a 20-Year-Old Patient with Negative DNAJB9 and Congo Red Fibrillary Deposits
October 22, 2026 | 10:00 AM - 12:00 PM
Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
Case of Isolated Proteinuria That Resolves with Rest
October 22, 2026 | 10:00 AM - 12:00 PM
Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
Dual-Disease Management: Combining Biologic and Mucosal-Targeted Therapy in Ankylosing Spondylitis (AS) and IgAN
October 22, 2026 | 10:00 AM - 12:00 PM
Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
Fulminant Crescentic IgAN with Renal-Limited Thrombotic Microangiopathy Progressing to Kidney Failure Despite Complement Inhibition
October 22, 2026 | 10:00 AM - 12:00 PM
Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
Refractory Nephrotic Syndrome Treated with Off-Label Obinutuzumab
October 22, 2026 | 10:00 AM - 12:00 PM
Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
An Unusual Case of Crescentic IgAN That Exemplifies the Complexity of Diagnosis and Management
October 22, 2026 | 10:00 AM - 12:00 PM
Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
Infection-Related Glomerular Injury: Malaria Unmasking IgAN
October 22, 2026 | 10:00 AM - 12:00 PM
Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
When Biopsy Raises More Questions Than Answers: Immune-Mediated Glomerulonephritis (GN) in a Pregnant Appalachian Woman
October 22, 2026 | 10:00 AM - 12:00 PM
Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
Proteinuria in Diagnostic Limbo: Unraveling an Atypical Cause of Proteinuria
October 22, 2026 | 10:00 AM - 12:00 PM
Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
Biopsy-Proven IgAN in a Patient with Longstanding Diabetes and Progressive CKD
October 22, 2026 | 10:00 AM - 12:00 PM
Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
IgAN: An Inside Job
October 22, 2026 | 10:00 AM - 12:00 PM
Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
Concomitant Biopsy-Proven ANCA-Associated Vasculitis (AAV) and Skin IgA Vasculitis
October 22, 2026 | 10:00 AM - 12:00 PM
Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
A Case on Emerging Therapies in Refractory IgAN
October 22, 2026 | 10:00 AM - 12:00 PM
Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
The Great Masquerade: Beyond Textbook Seronegative Immune Complex Glomerulopathy
October 22, 2026 | 10:00 AM - 12:00 PM
Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
How Late Is Too Late? Treating Advanced IgAN
October 22, 2026 | 10:00 AM - 12:00 PM
Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
Who's in the Driver's Seat? IgAN vs. FSGS as Competing Drivers of Progressive CKD in the Setting of a Variant of Uncertain Significance
October 22, 2026 | 10:00 AM - 12:00 PM
Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
Crohn Disease Complicated by IgA Vasculitis-Associated Nephritis: Renal Outcomes After Ustekinumab-Maintained Intestinal Remission
October 22, 2026 | 10:00 AM - 12:00 PM
Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
Under the Shadow of Stones: Adalimumab-Induced IgA Vasculitis with Renal Involvement
October 22, 2026 | 10:00 AM - 12:00 PM
Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
A Toothache with a Twist: Dental Abscess Unmasking IgAN
October 22, 2026 | 10:00 AM - 12:00 PM
Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
IgAN-Associated Systemic Lupus Erythematosus
October 22, 2026 | 10:00 AM - 12:00 PM
Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
Combination Therapy in IgAN: A Patient Treated with Atrasentan and Targeted-Release Budesonide
October 22, 2026 | 10:00 AM - 12:00 PM
Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
Living with IgAN: A Patient Diary Study
October 22, 2026 | 10:00 AM - 12:00 PM
Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
Deep Shotgun Metagenomics Reveals Plasmid-Mediated Oral Microbial Mechanisms Underlying Pathogenic IgA Production in IgAN
October 22, 2026 | 10:00 AM - 12:00 PM
Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
Early Repeated Administration of a Novel IgG-Degrading Enzyme, Ricefidase, for Anti-GBM Disease: A Phase 2, Open-Label, Single-Arm, Multicenter Study
October 22, 2026 | 10:00 AM - 12:00 PM
Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.